Allspring Global Investments’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-253
Closed -$8.12K 2697
2023
Q3
$8.12K Buy
+253
New +$8.6K ﹤0.01% 2632
2023
Q1
Sell
-2,119
Closed -$72.3K 2929
2022
Q4
$72.3K Sell
2,119
-3,201
-60% -$107K ﹤0.01% 2200
2022
Q3
$161K Sell
5,320
-2,119
-28% -$72.7K ﹤0.01% 1889
2022
Q2
$276K Sell
7,439
-10,501
-59% -$407K ﹤0.01% 1728
2022
Q1
$813K Sell
17,940
-364
-2% -$15.9K ﹤0.01% 2006
2021
Q4
$881K Buy
+18,304
New +$922K ﹤0.01% 2015

Other funds holding SRDX

Allspring Global Investments's SRDX Position: Q4 2023 in Review

Allspring Global Investments sold out of Surmodics (SRDX) in Q4 2023, closing a stake of 253 shares — an estimated $8.12K sold.

Allspring Global Investments first reported a position in SRDX in Q4 2021 and held it in 6 quarters. The position peaked at $881K in Q4 2021. 117 funds tracked by Wall St. Rank hold SRDX as of Q4 2023.

  • Allspring Global Investments reported no remaining Surmodics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 253 Surmodics shares in Q4 2023, an estimated $8.12K.
  • Allspring Global Investments first reported a position in Surmodics in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's Surmodics position peaked at $881K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Surmodics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.